[Membranoproliferative glomerulonephritis].
Kondo
Shuji
S
Department of Pediatrics, The Institute of Health Bioscience, The University of Tokushima Graduate School.
Kagami
Shoji
S
D003167:Complement Activation; D003178:Complement C3 Nephritic Factor; D003520:Cyclophosphamide / Q000008:administration & dosage; D016572:Cyclosporine / Q000008:administration & dosage; D004359:Drug Therapy, Combination; D015432:Glomerulonephritis, Membranoproliferative / Q000145:classification / Q000175:diagnosis / Q000276:immunology / Q000628:therapy; D006801:Humans; D007166:Immunosuppressive Agents / Q000008:administration & dosage; D008775:Methylprednisolone / Q000008:administration & dosage; D011239:Prednisolone / Q000008:administration & dosage; D011379:Prognosis; D020551:Pulse Therapy, Drug
D003178:Complement C3 Nephritic Factor; D007166:Immunosuppressive Agents; D016572:Cyclosporine; D003520:Cyclophosphamide; D011239:Prednisolone; D008775:Methylprednisolone